植入后内皮细胞损失的粘合镜 V4c:元分析
Filip Blazej Kisiel1, Gerard Jonathan Gurumurthy
1From the Department of Chemical Engineering, University of Manchester, Manchester, United Kingdom (Kisiel); Department of Medicine, University of Manchester, Manchester, United Kingdom (Gurumurthy).
Journal of cataract and refractive surgery
|January 9, 2024
概括
植入式眼镜 (ICL) V4c手术治疗近视后内皮细胞密度的损失在前三个月是最显著的. 这一元分析证实了ICL V4c的安全性,显示了与其他ICL模型相比的细胞损失.
科学领域:
- 眼科医生 眼科 眼科
- 生物材料科学 生物材料科学
背景情况:
- 内皮细胞密度 (ECD) 损失是可植入结膜透镜 (ICL) V4c手术用于近视纠正的已知的并发症.
- 现有的文献呈现出各种各样的ECD损失数据,使患者和临床医生的指导变得复杂.
结论:
- 针对近视纠正的ICL V4c手术表明内皮细胞密度损失的可预测模式.
- 这些发现证实了ICL V4c模型在内皮细胞健康方面的整体安全性.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...


